Search for: "Pfizer Inc. v. United States"
Results 221 - 228
of 228
Sorted by Relevance
|
Sort by Date
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
8 Nov 2007, 1:04 pm
Pfizer, Inc., 2006 WL 2819046, at *9 (D.N.J. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in… [read post]
10 Jan 2020, 9:32 am
Goodman Distr., Inc., 694 F. [read post]
13 Apr 2010, 9:45 am
For example, in 2009, Pfizer Inc. reached a settlement with the federal government and states over allegations of health care fraud contained in nine qui tam cases. [read post]
15 Mar 2007, 2:12 am
Geographical Distribution of Parties Though the geographical spread of named parties to WIPO UDRP cases (gTLD and ccTLD) reached 137 countries at the end of December 2006, the most frequently named party country both for complainants and for respondents continued to be the United States of America (USA). [read post]
14 Feb 2023, 12:29 pm
</span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <h2> <span style="font-weight: bold; display: initial;"> Patent Law </span> </h2> <p> <span style="display: initial;"> <br/> </span> </p> <p> <span style="display: initial;"> … [read post]
2 Apr 2012, 6:15 am
(In case you’re wondering, the remaining five are Microsoft, Pfizer, Exxon-Mobil, Johnson & Johnson and ADP.) [read post]
